Fasting Glucose and the Risk of Depressive Symptoms: Instrumental-Variable Regression in the Cardiovascular Risk in Young Finns Study
Wesołowska, Karolina; Elovainio, Marko; Hintsa, Taina; Jokela, Markus; Pulkki-Råback, Laura; Pitkänen, Niina; Lipsanen, Jari; Tukiainen, Janne; Lyytikäinen, Leo-Pekka; Lehtimäki, Terho; Juonala, Markus; Raitakari, Olli; Keltikangas-Järvinen, Liisa (2017)
Tässä tietueessa ei ole tiedostoja, ainoastaan metadata.
Wesołowska, Karolina
Elovainio, Marko
Hintsa, Taina
Jokela, Markus
Pulkki-Råback, Laura
Pitkänen, Niina
Lipsanen, Jari
Tukiainen, Janne
Lyytikäinen, Leo-Pekka
Lehtimäki, Terho
Juonala, Markus
Raitakari, Olli
Keltikangas-Järvinen, Liisa
Springer Verlag
2017
Kuvaus
peerReviewed
Tiivistelmä
Purpose
Type 2 diabetes (T2D) has been associated with depressive symptoms, but the causal direction of this association and the underlying mechanisms, such as increased glucose levels, remain unclear. We used instrumental-variable regression with a genetic instrument (Mendelian randomization) to examine a causal role of increased glucose concentrations in the development of depressive symptoms.
Method
Data were from the population-based Cardiovascular Risk in Young Finns Study (n = 1217). Depressive symptoms were assessed in 2012 using a modified Beck Depression Inventory (BDI-I). Fasting glucose was measured concurrently with depressive symptoms. A genetic risk score for fasting glucose (with 35 single nucleotide polymorphisms) was used as an instrumental variable for glucose.
Results
Glucose was not associated with depressive symptoms in the standard linear regression (B = −0.04, 95% CI [−0.12, 0.04], p = .34), but the instrumental-variable regression showed an inverse association between glucose and depressive symptoms (B = −0.43, 95% CI [−0.79, −0.07], p = .020). The difference between the estimates of standard linear regression and instrumental-variable regression was significant (p = .026)
Conclusion
Our results suggest that the association between T2D and depressive symptoms is unlikely to be caused by increased glucose concentrations. It seems possible that T2D might be linked to depressive symptoms due to low glucose levels.
Type 2 diabetes (T2D) has been associated with depressive symptoms, but the causal direction of this association and the underlying mechanisms, such as increased glucose levels, remain unclear. We used instrumental-variable regression with a genetic instrument (Mendelian randomization) to examine a causal role of increased glucose concentrations in the development of depressive symptoms.
Method
Data were from the population-based Cardiovascular Risk in Young Finns Study (n = 1217). Depressive symptoms were assessed in 2012 using a modified Beck Depression Inventory (BDI-I). Fasting glucose was measured concurrently with depressive symptoms. A genetic risk score for fasting glucose (with 35 single nucleotide polymorphisms) was used as an instrumental variable for glucose.
Results
Glucose was not associated with depressive symptoms in the standard linear regression (B = −0.04, 95% CI [−0.12, 0.04], p = .34), but the instrumental-variable regression showed an inverse association between glucose and depressive symptoms (B = −0.43, 95% CI [−0.79, −0.07], p = .020). The difference between the estimates of standard linear regression and instrumental-variable regression was significant (p = .026)
Conclusion
Our results suggest that the association between T2D and depressive symptoms is unlikely to be caused by increased glucose concentrations. It seems possible that T2D might be linked to depressive symptoms due to low glucose levels.
Avainsanat
Depressive symptoms, Fasting glucose, Hyperglycemia, Instrumental-variable regression, Mendelian randomization, Type 2 diabetes (T2D)